Catch up with tech transfer news from the past week with our regular roundup.
Last week’s news:
Juno brings big guns against cancer
Juno Therapeutics – a joint venture between Seattle and New York research centres – receives a massive $120m in series A backing.
Portland kickstarts six spin-outs
The Portland Development Commission seeds $30,000 each into six local spin-outs.
A group of leading Irish academic innovators win the opportunity to take their technologies to Silicon Valley.
Isis builds on China links with MESTAR
Isis Innovation’s 102nd spin-out for Oxford looks to build on links with China.
NYC launches $100m life sciences initiative
A venture capital initiative to launch more life science firms in New York City attracts more backers.
Early-stage biotech investor 5AM ready to roll on new fund worth $250m.
Arria NLG, a spin-out of Aberdeen, will float on AIM this week with a target of £102m market listing.
Canada’s CDRD spins out Sitka Biopharma to commercialise bladder cancer treatment.
Pulmocide breaths in big start from Imperial
Pulmocide, a spin-out of Imperial College London, receives £17m ($27.84m) from consortium headed by Imperial Innovations.
ImmunGene collects $9m series A
UCLA biotech spin-out ImmunGene receives $9m from life sciences investor Ally Bridge Group.
UK commercialisation firm the IP Group lands two pilot partnerships with UPenn and Columbia.
The UK’s Higher Education Funding Council for England launches a $2m programme to strengthen social entrepreneurship and enterprises in the country’s universities.
Technical University of Munich spin-out ImevaX partners with Project Pharmaceuticals on stomach pain.
Universities failing on tech transfer
The majority of US universities are failing to break even on technology transfer, a new report has indicated.
Kashef to heal Egypt’s mine scars
A startup of the American University in Cairo looks to clear land mines from the Egyptian desert.
Tokyo sees DNA’s commercial side
Tokyo spin-out Genequest set to open its doors for a walk-in DNA testing shop.
Commercialisation firm Fusion IP sets its sights on first investment deal for Swansea spin-out.
